MUSCLE WEAKNESS
I MADE BUDDY SETIAWAN
Cerebral Palsy
Mercer Rang (1990)
CP : is a result of demage of the developing brain that
produce disorder of movement and posture that is permanent
but “not unchanging”
5
Prenatal Perinatal Postnatal
Congenital infections Prematurity Infections
meningitis
Torches : Low birth weight Encephalitis
Toxoplasmosis
Rubela Complicated delivery Head trauma
Cytomegalovirus (dystocia)
Herpes asphysia Cerebrovascular accident
Syphylis cerebral trauma cyanotic cong. heart
disease
AIDS Infections sickle cell anaemia
menigitis vascular malformation
Abuse drugs: herpes
tobacco Cerebral anoxia
alcohol Hyperbillirubinaemia near drowning
marijuana Blood incomptabilities aspiration asphyxia
cocaine Other hemolytic disorder cardiac arrest
drugs seizures
Hypoglycaemia
Cerebral malformation Malnutrition
Obstetric complication
pre eclampsia/eclampsia
abruptio placentae
placenta praevia
6
Classification
3 Principle domains :
1. Movement
2. Anatomy
3. Function
7
Abnormal Movement
o Spasticity (60 – 80)%
o Dyskinesia (10 – 25)%
o Mixed (10 – 25)%
o Ataxia (2 – 5)%
o Hipotonia (2 – 5)%
8
Spasticity :
o velocity-dependent hyperactivity of stretch reflexes
o deep tendon reflexes increase
o clonus
o Pathologic reflexes
9
Anatomical (Topography)
1. Unilateral
monoplegia
hemiplegia
2. Bilateral
diplegia
triplegia
tetraplegia
10
11
12
13
Function Classification :
1. community ambulator
2. household ambulator
3. exercise ambulator
4. non-ambulator
14
Functional
o GMFCS
15
Pathology
1. Nervous system
1. Musculoskeletal
16
Nervous System by MRI
• white matter damage (prematurity) 43%
• basal ganglia damage 13%
• cortex/subcortical damage 9%
• CNS malformation 9%
• focal infarcts 7%
• others 7%
• normal MRI 12%
17
18
19
A. Periventricular Leucomalacia (P.V.L) or hemorrhage
in Premature infant 50%
in Full term (10 – 20)% } CP. diplegia
B. Thrombosis a. cerebralis media 30% CP. hemiplegia
20
Associate distrubances
o mental retardation and difficult to walk 40%
o epilepsy 30%
o Complex movement 20%
o Visual 16%
o malnutrition 15%
o hydrocephalus 14%
21
Musculoskeletal pathology
CP : - Static encephalopathy
- with progressive musculoskeletal pathology
22
Pathogenesis
1. Weakness
Upper motor neuron lesion causes :
• Loss of voluntary movement
• Weakness
• Easy fatigability
Pathogenesis
2. Spasticity
• Feature of all lesions of pyramidal system
• Abnormally increased contraction of a muscle related to excessive activity of disin
hibited spinal neurones
• Mediated via stretch reflex
• Tendon reflexes hypertonic
• Clonus may appear
• Posture characteristic because some neurones more active than others
• Attempts to change position lead to resistance which quickly yields clasp-knife ph
enomenon
Pathogenesis
3. Contracture
• Nature of muscle contracture : shortening of muscle-tendon unit due to f
ailure to keep pace with growth of bones
• Muscle adds sarcomeres at musculo-tendinous junction in response to c
onstant stretch
• In normal children, walking & movement provide all stretch needed
• When muscles spastic, this mechanism cannot occur
Pathogenesis
4. Deformity
• From unopposed muscle contracture
• Hip dislocation because of :
• Persistent hip adduction leads to valgus of femoral neck
• Persistent hip flexion leads to anteversion of femoral neck
• Results in acetabular dysplasia, hip subluxation & dislocation
Assesment : History
• Look for causes
Abnormal birth history, prematurity, neonatal nursery
• Normal development milestones
Head control, sitting independently, crawling, standing, walking
• Communication
Cognitive function, eye-sight
• Activity daily living
• Mobility
• Walking
Assesment : Examination
• Communication
• Muscles
• Spasticity vs contracture
• Psoas
• Hamstrings
• Adductor
• Quadriceps
• Triceps surae
• Posterior or anterior tibial muscles
• Peroneus
Assesment : Examination
• Neurology
• Gross weakness
• Clasp-knife phenomenon
• Primitive reflexes : Moro reflex, Labyrinthine reflex, Parachute reflex
• Upper limbs
• General conditions
• Look at resting point and contractures
• Asses joint stability
• Control
Treatment
Priorities :
1.Communication
2.Activities of daily living
3.Mobility in enviroment
4.Walking
Treatment
Objectivies :
1.Maintain straight spine and level pelvis
2.Maintain located, mobile, painless hips
3.Maintain plantigrade feet
4.Provide appropriate adaptive equipment, ex. Wheelchairs
5.Recognize and treat medical problems
Management acording to age, motor involvement, assosiate
d handicap, social condition
(0 – 3) years : - physiotherapy
(4 – 6) years : - physiotherapy
- surgery with appropriate indicatio
n
(7 – 8) years : - schooling, psychosocial development
- some surgery
more 18 years : - orientation to work
- residence
- marriage (independent)
32
Duchene Muscular Dystrhopy
INTRODUCTION
• Duchenne muscular dystrophy (DMD), included in a group of inflam
matory inherited disorders with progressive degeneration & weaknes
s of skeletal muscle without apparent cause in the peripheral CNS
CLASSIFICATION
SEX LINKED
• Duchenne
• Becker
• Emery-Dreifuss
AUTOSOMAL RECESSIVE
• Limb-girdle
• Infantile fascioscapulohumeral
AUTOSOMAL DOMINANT
• Fascioscapulohumeral
• Distal
• Ocular
• Oculopharyngeal
DEFINITION
• Progressive disease
• X-linked inheritence, affected boys >> with sex chrom
osome disorders
• Gene defect at locus p21
• Characteristic: X chromosome fails to produce dystrop
hin for Ca transport
• Unsuspected till the child start walking
Clinical Features
Genotype of DMD
• Females carry the DMD gene on the X
chromosome.
• Females are carriers and have a 50% chance
of transmitting the disease in each
pregnancy.
• Sons who inherit the mutation will have the
disease.
• Daughters that inherit the mutation will be
carriers.
• The DMD gene is located on the Xp 21 band
of the X chromosome.
• Mutations which affect the DMD gene.
• 96% are frameshift mutations
• 30% are new mutations
• 10-20% of new mutations occur in the
gametocyte (sex cell, will be pass on to the
next generation).
• The most common mutation are repeats of
the CAG nucleotides.
DMD Pedigree
The X chromosome carrying the disease-causing mutation can be tracked through the family. Note: Shaded squa
res = affected males: dots in circles = carrier females.
EPIDEMIOLOGY
• Affecting 1:3500 male infants
• Start at age 3-5 y.o with symmetric proximal greater than distal weakn
ess in the arms & legs
• By 6-9 y.o develop spesific Gower’s sign
• By 10-12 y.o fail to walk
PATHOLOGY
• Abnormality in gene that produce dystrophin.
• Absence or reduction of dystrophin destabilization of muscle cells
membrane allows Creatinine Phospo Kinase (CPK) to leak into seru
m with progressive loss of muscle & replacement by fibro – fatty tissu
e.
Symptoms of DMD
• Delayed developmental milestones
• Characteristic gait
• Calf hypertrophy
• Clumsiness/frequent falls
More Symptoms of DMD
• Muscle weakness
• Difficulty walking/running
SPESIFIC SIGN
• Gower’s sign : the child method of rising from the flo
or by climbing up his legs
• Due to weakness of gluteus maximus and thigh muscl
e
• By 10 y.o : unable to walk
• By 20 y.o : cardiac or respiratory failure death
DIAGNOSTIC
• Test for increased serum CPK : increased 200-400 times
• Characteristic on EMG
• Muscle biopsy for histochemical abnormalities : fibro – fatty tissue, re
placing muscle cells
• Decrased dystrophin ( immunohistochemical )
Immunolabeling of Muscle Biopsy Sections
Dystrophin antibod
y staining of muscle
cells